TG Therapeutics | TGTX - Ebitda



TG Therapeutics reported $12.28M in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
Alaunos Therapeutics USD 16.01M 17.16M Oct/2024
Amgen USD 3.6B 147M Jun/2025
Ardelyx USD -11872000 20.51M Jun/2025
Arrowhead Research USD -159327000 556.67M Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Dynavax Technologies USD -21594000 22.03M Mar/2025
Gilead Sciences USD 3.4B 797M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Novartis USD 6.17B 339M Jun/2025
PTC Therapeutics USD 971.14M 970.07M Mar/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 12.28M 17.68M Mar/2025
Vertex Pharmaceuticals USD 1.34B 556.6M Jun/2025